Velcicky, J. ., Bodendorf, U. ., Rigollier, P. ., Epple, R. ., Beisner, D. ., Guerini, D. ., … Brandl, T. . (2018). Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.7b01371 (Original work published 2018)